| 王学睿.日本药品研发的现状及动向[J].全球科技经济瞭望,2012,27(7):54~59 |
| 日本药品研发的现状及动向 |
| Status and trends of Japanese pharmaceutical R&D |
| 投稿时间：2011-02-08 修订日期：2011-02-08 |
| DOI：10.3772/j.issn.1009-8623.2012.07.008 |
| 中文关键词: 日本；药品；制药；专利保护 |
| 英文关键词: Japan；medicine；pharmaceutical；patent protection |
| 基金项目: |
|
| 摘要点击次数: 2886 |
| 全文下载次数: 2535 |
| 中文摘要: |
| 日本制药企业的新药研发创新能力近年来进步明显，涌现了一批具有世界水平的新药研发与生产企业。目前，各大制药企业均投入巨额研发经费，提前进行研发布局，以求在未来市场需求大的医药领域取得重大新药创制的突破。对日本药品的生产及销售状况、新药研发的现状与发展动向以及日本制药企业的研发重点和战略布局进行研究，以了解日本药品研发产业整体的发展概况及发展趋势。 |
| 英文摘要: |
| Japanese pharmaceutical company’s new drug research and innovation capacity has made significant progress in recent years, and a number of world-class new drug R&D and production enterprises have come into being. At present, major pharmaceutical companies have invested heavily in R&D expenditures, and carried out the R&D layout in advance, in order to obtain a breakthrough in creation and production of new drug in the future market. The paper analyses the situation of Japanese pharmaceutical production and sales, the status quo and development trends of new drug development, and the R&D priorities and strategic layout of pharmaceutical
companies in Japan. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
